Anders Lindahl is a Scientific Director in Pharmaceutics at Medical Products Agency Läkemedelsverket. With a background in biopharmaceutics and pharmacokinetics, Anders has extensive experience as a Pharmaceutical Assessor and Scientific Adviser in various pharmaceutical companies including Catalent Pharma Solutions and AstraZeneca. Anders holds a PhD in Biopharmaceutics from Uppsala University and has a strong expertise in areas such as in vitro in vivo correlations and bioequivalence. Prior to their current role, Anders worked as a Pharmacist at Apoteket AB.
December, 2023 - present
March, 2022
August, 2018
October, 2015
January, 2013